Beinaglutide showed significant weight‐loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real‐world setting: a 3‐month, multicentre, observational, retrospective, open‐label study

AIMS: The purpose of this study was to examine the effectiveness of beinaglutide on body weight, glycated haemoglobin (HbA(1c)), blood pressure and lipid profiles in patients with type 2 diabetes mellitus (T2DM) in a real‐world setting in China. MATERIALS AND METHODS: This was a multicentre, observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Y. L., Zhou, C., Li, X. F., Yang, M. N., Tao, L., Zheng, X. Y., Jia, Y. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700512/
https://www.ncbi.nlm.nih.gov/pubmed/31452921
http://dx.doi.org/10.1002/osp4.342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700512/
https://www.ncbi.nlm.nih.gov/pubmed/31452921
http://dx.doi.org/10.1002/osp4.342

Ejemplares similares